-+ 0.00%
-+ 0.00%
-+ 0.00%

Allarity Therapeutics Sees FY2026 GAAP EPS $(0.76)-$(0.73) vs $(0.80) Est

Benzinga·11/13/2026 13:30:02
Allarity Therapeutics (NASDAQ:ALLR) is looking for FY2026 GAAP EPS of $(0.76)-$(0.73) vs $(0.80) analyst estimate..